A Phase II Study Of Genasense [oblimersen] In Combination With Thalidomide And Dexamethasone In Relapsed And Refractory Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 29 Sep 2009
At a glance
- Drugs Oblimersen (Primary) ; Dexamethasone; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 29 Sep 2009 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 29 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.